Biological Information
Background Information:
Adenosine 5’-monophosphate (AMP)-activated protein kinase (AMPK) is a metabolic master switch, activated by exercise and muscle contraction. AMPK phosphorylate key target proteins that control glucose uptake, oxidation of fatty acids, cholesterol synthesis, lipogenesis, triglyceride synthesis, adipocyte lipolysis, glycolysis and nitric oxide synthesis. Metabolic deficiencies or inhibition of AMPK signaling system may result in impaired glucose tolerance and Type 2 diabetes mellitus and contribute to lipid accumulation.
Family:
Kinase
Protein Name:
AMPK
Uniprot Number:
Q13131
Protein Aliases:
Acetyl-CoA carboxylase kinase
Accession Number:
NM_006251
Organism:
Human
Construct Details:
Full Length, Recombinant
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Enzymatic
Functional Mode:
Agonist
Detection Method:
Radiometry
Measured Response:
Radiometry
Testing Information
Procedure Summary:
Human recombinant protein kinase AMPK (A1/B1/G1) expressed in insect cells is used. Test compound or 1 µM A769662 or vehicle is preincubated with 0.24 µg/ml of enzyme in modified MOPS buffer pH 7.2 for 15 minutes at 37C. The reaction is initiated by addition of 10 mM SAMS peptide, 1 mM ATP and 0.25 mCi [g32P]ATP for another 30 minute incubation period and terminated by further addition of 3% H3PO4. After harvesting, filtermats are counted to determine the amount of [32P]SAMS peptide formed. Compounds are screened at 10 µM.
Substrate:
10 µM SAMS peptide
Incubation:
30 min at 37°C
Control Inhibitor:
A769662
Criteria For Significance:
≥ 50% of max stimulation
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
10
Turnaround Time
Standard:
15 Business Days
Clinical Relevance
Therapeutic Area:
Metabolic Diseases
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei
RELATED SOLUTIONS